Cepheid Acquires UK Diagnostics Distributor for $1.9M | GenomeWeb
NEW YORK (GenomeWeb News) – Cepheid today said that it will acquire Stretton Scientific, a UK-based distributor of diagnostic and monitoring equipment, for around £1.2 million ($1.9 million).
Privately held Stretton already distributes Cepheid’s SmartCycler system to customers, including the National Health Service, throughout the UK. The acquisition is expected to “augment our newly established UK-based direct sales team,” Cepheid CEO John Bishop said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.